IRF4 and Wilson disease: Cells from individuals heterozygous for the R98W mutation (patients and healthy carriers) had higher IRF4 mRNA levels than those from WT homozygous relatives, unrelated WD cohort patients and EBV-B cells from healthy unrelated controls (Figure 4A).